Abstract

The major DNA cytosine methyltransferase isoform in mouse erythroleukemia cells, Dnmt1, exhibits potent dead-end inhibition with a single-stranded nucleic acid by binding to an allosteric site on the enzyme. The previously reported substrate inhibition with double-stranded substrates also involves binding to an allosteric site. Thus, both forms of inhibition involve ternary enzyme-DNA-DNA complexes. The inhibition potency of the single-stranded nucleic acid is determined by the sequence, length, and most appreciably the presence of a single 5-methylcytosine residue. A single-stranded phosphorothioate derivative inhibits DNA methylation activity in nuclear extracts. Mouse erythroleukemia cells treated with the phosphorothioate inhibitor show a significant decrease in global genomic methylation levels. Inhibitor treatment of human colon cancer cells causes demethylation of the p16 tumor suppressor gene and subsequent p16 re-expression. Allosteric inhibitors of mammalian DNA cytosine methyltransferases, representing a new class of molecules with potential therapeutic applications, may be used to elucidate novel epigenetic mechanisms that control development.

Highlights

  • The patterns of DNA cytosine methylation in mammals evolve throughout development [1]

  • Poly(dI1⁄7dC) and hemimethylated (CGG/CCG)12, a 36-bp fragment containing the triplet repeat sequence in which expansion in the FMR1 gene causes fragile-X syndrome, show complex kinetics consistent with DNA binding to an allosteric site, no such behavior is observed with unmethylated

  • The relative velocities versus S/Km plots conveniently normalize the data between the two Allosteric DNA Cytosine Methyltransferase Inhibitor diverse DNA substrates

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—S-Adenosyl-L-[methyl-3H]methionine (75 Ci/mmol, 1 mCi/ ml ϭ 37 GBq) was purchased from Amersham Biosciences. The poly(dI1⁄7dC) concentrations were ϳ2.0, 4.0, 8.0, 16, 35, 80, 160, 250, 400, 700, and 1000 picomolar in duplex DNA; Dnmt was 3.0 nM. Inhibition with Single-stranded Oligonucleotides—Initial velocity data were collected with poly(dI1⁄7dC), AdoMet, GC-boxb, and GC-boxbMET at the concentrations indicated in Fig. 2 legend. IC50 determinations with GC-boxbMET, GC-boxpMET, GC-boxcMET, GC-boxdMET, GC-boxeMET, and CRE used 4 nM Dnmt and 50 pM poly(dI1⁄7dC). The reaction was stopped after 60 min, and label incorporation into DNA was determined as described [41]. Mouse Erythroleukemia Cell Studies—MEL cells, prepared as described [41] to a density of 106/ml, were treated with inhibitors (7.7 ␮M GC-boxpMET, 1.5 ␮M 5AC, or 18 ␮M antisense oligonucleotide) along with LipofectAMINE as described by the manufacturer. Amplification was the same as p16 with the exception of using an annealing temperature of 60 °C and 27 amplification cycles

RESULTS AND DISCUSSION
TABLE I In vitro inhibition analysis of oligonucleotides
ND ND ND ND ND nM
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call